In the current study, novel amino acid polymorphisms in HLA class II molecules in patients with ICI-T1DM, and in vitro proinsulin epitope binding affinities to HLA-DP molecules were revealed. The gene discussed is HLA-DPA1; the disease is type 1 diabetes mellitus.